期刊文献+

Nm23-H1在小细胞肺癌中的表达及其与预后的关系 被引量:3

Expression of Nm23-H1 and its relationship with prognosis in patients with small cell lung cancer
原文传递
导出
摘要 目的探讨肿瘤转移抑制因子Nm23-H1在小细胞肺癌(small cell lung cancer,SCLC)中的表达及其与预后的关系。方法通过免疫组化S-P法检测71例SCLC组织和22例正常肺组织中Nm23-H1蛋白表达情况,根据染色强度和阳性肿瘤细胞数目所占百分比,将其分为高、低表达两组,使用SPSS19.0软件统计分析Nm23-H1的表达与临床病理及预后的关系。结果正常肺组织中Nm23-H1蛋白表达显著高于SCLC组织(90.9%vs57.7%,P〈0.01);局限期患者Nm23.H1蛋白表达显著高于广泛期患者(66.7%掷39.1%,P〈0.05)。多因素Logistic回归分析显示,Nm23-H1蛋白可作为SCLC是否转移的独立保护因素(OR=0.32,95%C1=0.12—0.90,P〈0.05)。亚细胞定位在正常肺组织与肺癌组织中没有差异,在不同分期之间也没有差异。多因素COX风险回归分析表明只有临床分期为广泛期和年龄I〉60岁是SCLC患者总生存的劣势预后因素(年龄:HR=1.03,95%C1=1.00—1.05,P〈0.05;临床分期:HR:1.85,95%CI=1.03~3.33,P〈0.05)。Nm23.H1蛋白表达及亚细胞定位与SCLC患者生存期都没有显著相关性。结论Nm23-H1在SCLC组织中以细胞质表达为主的低表达,低表达与SCLC的远处转移密切相关,可能是SCLC预后不良的指标之一。 Objective To study the expression of Nm23-H1 and its relationship with prognosis in patients with small cell lung cancer. Methods The expression of Nm23-H1 was detected by immunohisto- chemistry in 71 small cell lung cancer tissue samples and 22 normal lung tissue samples. According to their positive percentage and staining intensity, they were divided into 2 groups:high expression group and low expression group. The correlation of Nm23-H1 expression with clinicopathology and prognosis was performed by SPSS 19.0. Results The positive rate of Nm23-H1 was higher in normal tissue samples than in small cell lung cancer(90.9% vs 57.7% ,P 〈 0.05 ) ;It was higher in limited stage than in extensive stage small cell lung cancer(66.7% vs 39.1% ,P 〈 0.05 )o Multivariate logistic regression showed the Nm23-H1 expression was an independent protect factor for the metastasis of small cell lung cancer ( OR =0.32,95% CI =0.12 -0. 90 ,P 〈 0.05 ). The subcellular location of the Nm23-H1 showed no difference between normal lung tissues and cancer tissues, neither between different stages. In the survival analysis, Nm23-H1 positive expression was found to be related with decreased median overall survival than negative expression patients (P 〈 0.05 ). The stage was also associated with mOS that the patients with limited foei stayed longer than those with metastastic diesease ( HR = 1.85, 95% CI = 1.03 -3.63, P 〈 0.05). Conclusion Nm23-H1 is midly expressed in SCLC cancer tissues, and mainly in the cytoplasma. The expression plays an important role in the metastasis of SCLC, and may be a predictive factor for the poor outcome of SCLC.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2014年第10期983-986,共4页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(81272599)~~
关键词 小细胞肺癌 转移 NM23-H1 预后 small cell lung cancer metastasis Nm23-H1 prognosis
  • 相关文献

参考文献5

二级参考文献57

共引文献31

同被引文献40

  • 1王泽洲,郑莹.1990年至2020年间全球及我国肺癌的发病流行趋势及防控措施[J].诊断学理论与实践,2023,22(1):1-7. 被引量:54
  • 2Metro G,Ricciuti B,Chiari R,et al.Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung:Implications for clinical practice[J].Lung Cancer,2016,95:82-97.
  • 3Sharp A,Bhosle J,Abdelraouf F,et al.Development of molecularly targeted agents and immunotherapies in small cell lung cancer[J].Eur J Cancer,2016,6(60):26-39.
  • 4Hamilton G,Rath B.Smoking,inflammation and small cell lung cancer:recent developments[J].Wien Med Wochenschr,2015,165(19-20):379-386.
  • 5Zhang H,Li X,Ge L,et al.Methylation of Cp G island of p14(ARK),p15(INK4b)and p16(INK4a)genes in coke oven workers[J].Hum Exp Toxicol,2015,34(2):191-197.
  • 6Korse CM,Holdenrieder S,Zhi XY,et al.Multicenter evaluation of a new progastrin-releasing peptide(Pro GRP)immunoassay across Europe and China[J].Clin Chim Acta,2015,1(438):388-395.
  • 7Kumar A,Rajendran V,Sethumadhavan R,et al.CEP proteins:the knights of centrosome dynasty[J].Protoplasma,2013,250(5):965-983.
  • 8Wang B,He YJ,Tian YX,et al.Clinical utility of haptoglobin in combination with CEA,NSE and CYFRA21-1 for diagnosis of lung cancer[J].Asian Pac J Cancer Prev,2014,15(22):9611-9614.
  • 9Inomata M,Hayashi R,Yamamoto A,et al.Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib[J].Mol Clin Oncol,2015,3(4):802-806.
  • 10Torsetnes SB,Broughton MN,Paus E,et al.Determining Pro GRP and isoforms in lung and thyroid cancer patient samples:comparing an MS method with a routine clinical immunoassay[J].Anal Bioanal Chem,2014,406(11):2733-2738.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部